by Stem Cell Network | Aug 25, 2010
Right now, you’re seeing this blog post thanks to your cornea. In concert with your eye’s lens, the cornea refracts light and allows you to distinguish the letters on this page from the background. But your cornea is vulnerable to disease — clouding...
by Allison Van Winkle | Aug 16, 2010
There are currently over 100,000 people in the United States on the waiting list for an organ transplant. Between January and March of 2010, fewer than 7,000 patients received transplants. Imagine, as an alternative to donated live tissue, a tissue-engineered...
by Katie Moisse | Jul 29, 2010
Buried deep within our bony skulls and spinal columns, and separated from our blood by an infallible barrier, our neurons are, I would argue, the most protected cells in our bodies. This is a good thing for obvious reasons. This is a bad thing, however, for scientists...
by Chris Kamel | Jul 20, 2010
There’s a scene in The Simpsons, after Homer suffers from a heart attack, where he paraphrases Friedrich Nietzsche’s famous words, “That which does not kill us makes us stronger.” Those words, in this situation, are overly optimistic. After an...
by Paul Krzyzanowski | Jul 8, 2010
The concept of personalized medicine is an intuitive one: knowing what treatment to provide a patient based on their own individual case of a disease. Molecular techniques and various flavours of “-omics” provide high precision in determining the status and types of...
by Stem Cell Network | Jul 6, 2010
by Tania Bubela Increasingly, commercialization is a key requirement for securing project funding and support for scientific research. The field of stem cell research is no exception. But does this emphasis on commercialization, which necessarily involves issues of...
Comments